Scott Rollins
Vorstandsvorsitzender bei Tetherex Pharmaceuticals Corp.
Profil
Scott A.
Rollins is the founder of Alexion Pharmaceuticals, Inc., which was founded in 1992.
He held the title of SVP-Drug Development & Project Management from 1992 to 2011.
Dr. Rollins currently holds the position of Chairman & Chief Executive Officer at Tetherex Pharmaceuticals Corp.
and is also a Director at Moat Biotechnology Corp.
In the past, Dr. Rollins served as the President, Chief Executive Officer & Director at Selexys Pharmaceuticals Corp.
and as the Chief Operating Officer at Innovative Tap Solutions LLC.
Dr. Rollins obtained his undergraduate and doctorate degrees from the University of Oklahoma.
Aktive Positionen von Scott Rollins
| Unternehmen | Position | Beginn |
|---|---|---|
Tetherex Pharmaceuticals Corp.
 Tetherex Pharmaceuticals Corp. BiotechnologyHealth Technology Tetherex Pharmaceuticals Corp. operates as a biopharmaceutical company. It focuses on development of therapeutics for the treatment of thrombosis, inflammation and tumor metastasis across a broad range of severe diseases. The company was founded by Rodger P. McEver and Richard D. Cummings and is headquartered in Oklahoma City, OK. | Vorstandsvorsitzender | - |
Moat Biotechnology Corp.
 Moat Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Moat Biotechnology Corp. is a biopharmaceutical company that focuses on developing vaccines. The company is based in Oklahoma City, OK. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Scott Rollins
| Unternehmen | Position | Ende |
|---|---|---|
Selexys Pharmaceuticals Corp.
 Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Vorstandsvorsitzender | - |
Innovative Tap Solutions LLC
 Innovative Tap Solutions LLC Industrial MachineryProducer Manufacturing Innovative Tap Solutions LLC provides self-pour technology for bars, restaurants, hotels, and businesses to increase profits, reduce waste, and improve user experience. The company is based in Wheeling, IL. The company offers custom-built screens and tap walls that have been boosting revenue and solving complex staffing issues for bars worldwide. PourMyBeer's self-contained tap stations can easily be moved to wherever there is a power outlet and ethernet connection, allowing flexibility in venue layout and use. The company was founded in 2009 by Josh Goodman, who has been the CEO since then. | Geschäftsführer | - |
| ALEXION PHARMACEUTICALS, INC. | Gründer | - |
Ausbildung von Scott Rollins
| University of Oklahoma | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Selexys Pharmaceuticals Corp.
Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Health Technology |
Tetherex Pharmaceuticals Corp.
Tetherex Pharmaceuticals Corp. BiotechnologyHealth Technology Tetherex Pharmaceuticals Corp. operates as a biopharmaceutical company. It focuses on development of therapeutics for the treatment of thrombosis, inflammation and tumor metastasis across a broad range of severe diseases. The company was founded by Rodger P. McEver and Richard D. Cummings and is headquartered in Oklahoma City, OK. | Health Technology |
Innovative Tap Solutions LLC
Innovative Tap Solutions LLC Industrial MachineryProducer Manufacturing Innovative Tap Solutions LLC provides self-pour technology for bars, restaurants, hotels, and businesses to increase profits, reduce waste, and improve user experience. The company is based in Wheeling, IL. The company offers custom-built screens and tap walls that have been boosting revenue and solving complex staffing issues for bars worldwide. PourMyBeer's self-contained tap stations can easily be moved to wherever there is a power outlet and ethernet connection, allowing flexibility in venue layout and use. The company was founded in 2009 by Josh Goodman, who has been the CEO since then. | Producer Manufacturing |
Moat Biotechnology Corp.
Moat Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Moat Biotechnology Corp. is a biopharmaceutical company that focuses on developing vaccines. The company is based in Oklahoma City, OK. | Health Technology |
